{"id":"i-123-mibg","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"I-123 mIBG is a radioligand that selectively binds to norepinephrine transporters in the body, allowing for imaging of these transporters in various conditions.","oneSentence":"I-123 mIBG binds to norepinephrine transporters","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:34:40.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Thyroid cancer"}]},"trialDetails":[{"nctId":"NCT07437963","phase":"PHASE1, PHASE2","title":"Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-05-01","conditions":"Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma, Refractory Ganglioneuroblastoma","enrollment":76},{"nctId":"NCT06858501","phase":"PHASE2","title":"Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-22","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, High Risk Neuroblastoma","enrollment":84},{"nctId":"NCT04386317","phase":"PHASE2","title":"Terazosin Effect on Cardiac Changes in Early Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-11-01","conditions":"REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease","enrollment":15},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT05401630","phase":"NA","title":"Mental Stress Reactivity in Women With CMD","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-07-19","conditions":"Post-menopause","enrollment":150},{"nctId":"NCT01757626","phase":"PHASE1, PHASE2","title":"Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-12","conditions":"Neuroblastoma","enrollment":186},{"nctId":"NCT04385277","phase":"PHASE2","title":"Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-12-31","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":41},{"nctId":"NCT00673010","phase":"PHASE1","title":"Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2005-03-07","conditions":"Thyroid Cancer","enrollment":20},{"nctId":"NCT07195500","phase":"","title":"Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-12-25","conditions":"Neuroblastoma, Pheochromocytoma, Paraganglioma","enrollment":30},{"nctId":"NCT07111117","phase":"PHASE2","title":"Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.","status":"NOT_YET_RECRUITING","sponsor":"Institut Curie","startDate":"2026-03-01","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT07064746","phase":"","title":"Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-07-10","conditions":"Neuroblastoma (NB)","enrollment":150},{"nctId":"NCT05514106","phase":"PHASE4","title":"MIBG in Aging and Neurologic Disorders","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2023-05-08","conditions":"Lewy Body Disease, Dementia, Parkinsonism","enrollment":50},{"nctId":"NCT06120049","phase":"PHASE2, PHASE3","title":"[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD","status":"RECRUITING","sponsor":"prof. dr. Koen Van Laere","startDate":"2024-01-19","conditions":"Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy","enrollment":113},{"nctId":"NCT04510311","phase":"EARLY_PHASE1","title":"Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2020-10-19","conditions":"Neuroendocrine Tumors","enrollment":32},{"nctId":"NCT06745011","phase":"","title":"Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System","status":"ENROLLING_BY_INVITATION","sponsor":"University of Aarhus","startDate":"2024-05-13","conditions":"Polyneuropathy, Alpha-Synucleinopathy, Lewy Body Disease","enrollment":100},{"nctId":"NCT05826158","phase":"NA","title":"18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2022-06-06","conditions":"Neuroblastoma","enrollment":25},{"nctId":"NCT01568177","phase":"NA","title":"Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-02","conditions":"Microvascular Coronary Dysfunction","enrollment":105},{"nctId":"NCT04559217","phase":"PHASE2","title":"68Ga-DOTATATE Neuroblastoma Imaging Pilot","status":"RECRUITING","sponsor":"Centre de recherche du Centre hospitalier universitaire de Sherbrooke","startDate":"2021-12-06","conditions":"Neuroblastoma","enrollment":20},{"nctId":"NCT05069220","phase":"EARLY_PHASE1","title":"18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2021-09-01","conditions":"Neuroendocrine Tumor, Neuroblastoma, Pheochromocytoma","enrollment":150},{"nctId":"NCT04776642","phase":"","title":"Biobank for \"Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment\"","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-12-18","conditions":"Arrythmia, Conduction Disorder, Pathophysiology","enrollment":1000},{"nctId":"NCT05948137","phase":"","title":"F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma","status":"TERMINATED","sponsor":"Asan Medical Center","startDate":"2017-09-21","conditions":"Pheochromocytoma, Paraganglioma","enrollment":32},{"nctId":"NCT03217227","phase":"","title":"Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR","status":"UNKNOWN","sponsor":"National Heart Centre Singapore","startDate":"2017-05-01","conditions":"Ischemic Heart Disease, Coronary Artery Disease, Cardiovascular Diseases","enrollment":300},{"nctId":"NCT01912040","phase":"","title":"Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2006-07","conditions":"Adrenergic Pathology","enrollment":""},{"nctId":"NCT03717207","phase":"","title":"Cardiac Autonomic Dysfunction in Diabetics Patients With Syncope","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2010-01-01","conditions":"Syncope, Vasovagal","enrollment":242},{"nctId":"NCT03469843","phase":"","title":"Characterization of the Cardiac Reinnervation of Patients With Transposition of the Great Arteries Long After Repair With the Arterial Switch Operation. Correlation With Electrocardiographic and Exercise Test Parameters","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2018-04-19","conditions":"Congenital Heart Disease, Congenital Heart Defect, Transposition of the Great Arteries","enrollment":25},{"nctId":"NCT02279030","phase":"","title":"Use of MIBG Scan Images in PVC Ablations","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2015-06","conditions":"Premature Ventricular Contractions","enrollment":20},{"nctId":"NCT01250912","phase":"NA","title":"Imaging With a Radio Tracer to Guide VT Ablations","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-03","conditions":"Ventricular Tachycardia, Arrhythmia","enrollment":20},{"nctId":"NCT02043899","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma","status":"COMPLETED","sponsor":"Cancer Research UK","startDate":"2014-02","conditions":"Metastatic Neuroblastoma","enrollment":36},{"nctId":"NCT03667989","phase":"NA","title":"SPECT-based Prediction and Evaluation of CRT Efficacy in CHF","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2017-09-01","conditions":"Chronic Heart Failure","enrollment":60},{"nctId":"NCT01940081","phase":"","title":"The Leiden Nonischemic Cardiomyopathy Study","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2011-10","conditions":"Cardiomyopathy, Dilated, Tachycardia, Ventricular, Ventricular Fibrillation","enrollment":148},{"nctId":"NCT00126412","phase":"PHASE3","title":"Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2005-08-02","conditions":"Pheochromocytoma, Neuroblastoma","enrollment":251},{"nctId":"NCT02656329","phase":"PHASE3","title":"International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device","status":"TERMINATED","sponsor":"GE Healthcare","startDate":"2015-12-30","conditions":"Heart Failure","enrollment":395},{"nctId":"NCT03094910","phase":"NA","title":"Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon","status":"COMPLETED","sponsor":"Herlev Hospital","startDate":"2017-01-01","conditions":"Raynaud Disease, Raynaud Phenomenon, Hand and Arm Vibration Syndrome","enrollment":174},{"nctId":"NCT03227393","phase":"NA","title":"The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG","status":"WITHDRAWN","sponsor":"University of Cincinnati","startDate":"2017-09-30","conditions":"Heart Failure, Systolic","enrollment":""},{"nctId":"NCT00126438","phase":"PHASE3","title":"Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2005-07","conditions":"Heart Failure, Congestive","enrollment":515},{"nctId":"NCT00491387","phase":"PHASE4","title":"Sympathetic Nervous System Modulation in Hypertension","status":"TERMINATED","sponsor":"University of Cincinnati","startDate":"2007-08","conditions":"Hypertension","enrollment":24},{"nctId":"NCT01185756","phase":"NA","title":"MIBG Scintigraphy as a Tool for Selecting Patients Requiring Implantable Cardioverter Defibrillator (ICD)","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-09","conditions":"Heart Failure, Sudden Death","enrollment":330},{"nctId":"NCT01868841","phase":"PHASE4","title":"123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System","status":"COMPLETED","sponsor":"Timothy M. Bateman","startDate":"2013-12","conditions":"Heart Failure, Cardiomyopathy","enrollment":45},{"nctId":"NCT01919983","phase":"","title":"Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-03","conditions":"Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Inflammation","enrollment":28},{"nctId":"NCT00028106","phase":"PHASE2","title":"131MIBG to Treat Malignant Pheochromocytoma","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2001-12-05","conditions":"Pheochromocytoma","enrollment":32},{"nctId":"NCT01522378","phase":"PHASE1","title":"Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2012-02","conditions":"Congestive Heart Failure","enrollment":14},{"nctId":"NCT00785044","phase":"","title":"Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2008-05","conditions":"Congestive Heart Failure","enrollment":471},{"nctId":"NCT02043522","phase":"PHASE3","title":"123I-mIBG SPECT Imaging","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2013-12","conditions":"Heart Failure, Coronary Artery Disease","enrollment":30},{"nctId":"NCT01258283","phase":"","title":"PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2011-06","conditions":"Defibrillators, Implantable","enrollment":6},{"nctId":"NCT02071680","phase":"PHASE3","title":"Autonomic Innervation and MIBG Imaging","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2015-03","conditions":"Atrial Fibrillation","enrollment":5},{"nctId":"NCT00126425","phase":"PHASE3","title":"Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2005-07","conditions":"Heart Failure, Congestive","enrollment":587},{"nctId":"NCT01936649","phase":"PHASE4","title":"Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2013-08","conditions":"Heart Failure (HF), Ventricular Dysfunction, Left","enrollment":63},{"nctId":"NCT01432626","phase":"NA","title":"Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2011-09","conditions":"Stress Induced Cardiomyopathy","enrollment":10},{"nctId":"NCT02515812","phase":"NA","title":"Comparative Study of Cardiac Adrenergic Function Explored by I-123-MIBG and CZT Camera (D-SPECT) Versus Anger Camera in Patients With Heart Failure","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2012-10","conditions":"Heart Failure","enrollment":45},{"nctId":"NCT01775215","phase":"","title":"A Comparison of Advanced Imaging Techniques in Aortic Stenosis","status":"WITHDRAWN","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2013-01","conditions":"Aortic Stenosis","enrollment":""},{"nctId":"NCT02173834","phase":"NA","title":"Brown Adipose Tissue and Body Mass Index","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-03","conditions":"Obesity, Type 2 Diabetes Mellitus","enrollment":20},{"nctId":"NCT02130154","phase":"","title":"Brown Adipose Tissue Activity and Age","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-05","conditions":"Obesity, Ageing","enrollment":16},{"nctId":"NCT01943097","phase":"","title":"Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2007-06","conditions":"Neuroblastoma","enrollment":160},{"nctId":"NCT01931488","phase":"PHASE2","title":"124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2013-08","conditions":"Parkinson Disease, Neuroendocrine Tumors","enrollment":40},{"nctId":"NCT01730417","phase":"PHASE1","title":"Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG","status":"COMPLETED","sponsor":"Bennett Chin","startDate":"2009-11","conditions":"Neuroendocrine Tumors, Heart Failure","enrollment":12},{"nctId":"NCT01448083","phase":"","title":"Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours","status":"UNKNOWN","sponsor":"Nuclear Medicine Consultants, Inc.","startDate":"2011-10","conditions":"Neuroendocrine Tumor","enrollment":40},{"nctId":"NCT01218191","phase":"","title":"Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2010-02","conditions":"Subarachnoid Hemorrhage","enrollment":30},{"nctId":"NCT00296738","phase":"","title":"123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2007-05","conditions":"Cardiac Diseases","enrollment":50},{"nctId":"NCT01373736","phase":"PHASE3","title":"123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors","status":"UNKNOWN","sponsor":"Vancouver Coastal Health","startDate":"","conditions":"Pheochromocytoma, Neuroblastoma, Paraganglioma","enrollment":""},{"nctId":"NCT00730444","phase":"","title":"Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma","status":"APPROVED_FOR_MARKETING","sponsor":"GE Healthcare","startDate":"","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00590096","phase":"","title":"I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"1991-01","conditions":"Neuroblastoma, Pheochromocytoma","enrollment":1380}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":196,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"I-123 mIBG","genericName":"I-123 mIBG","companyName":"GE Healthcare","companyId":"ge-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"I-123 mIBG binds to norepinephrine transporters Used for Thyroid cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}